0001237899-18-000021.txt : 20181214 0001237899-18-000021.hdr.sgml : 20181214 20181214161816 ACCESSION NUMBER: 0001237899-18-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181212 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 181235778 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-12-12 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller Common Stock 2018-08-30 5 G 0 50 0.0 D 1421 D Common Stock 2018-12-12 4 A 0 5000 0.0 A 6421 D Common Stock 2018-08-30 5 G 0 50 0.0 A 4347 I By Trust Common Stock 2018-10-25 5 G 0 2950 0.0 D 1397 I By Trust Common Stock 2018-10-25 5 G 0 2950 0.0 A 2950 I by 2018 GRAT Common Stock 1349 I By 401(k) Plan Common Stock 1424 I by 2017 GRAT Non-Qualified Stock Option (right to buy) 381.4 2018-12-12 4 A 0 11400 0.0 A 2028-12-12 Common Stock 11400 11400 D Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 12, 2023. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2018-12-13